Home > Patient Events > Living Strong with MPN: Navigating Everything from Treatment to Trials with Resilience
Living Strong with MPN - Replay Coming
Navigating Everything from Treatments to Clinical Trials with Resilience
Date
Held on Nov 14th, 2024
Replay coming soon – sign up to get alerted when it releases.
This program was a live in-person program in St. Louis, MO.
This program is for those affected by Polycythemia vera (PV), Essential thrombocythemia (ET), and myelofibrosis.
MPN Experts from Siteman Cancer Center
Dr. Stephen Oh is Associate Professor of Medicine and Co-Chief of the Division of Hematology and Dr. Amy Zhou is Associate Professor of Medicine in the Division of Hematology. They are both at Washington University School of Medicine. This program covered the following topics:
- Gain practical tools for monitoring symptoms, managing side effects, and improving your day-to-day life.
- Discover the latest treatment breakthroughs, including clinical trials, and what they mean for your future.
- Hear inspiring stories from others living with MPN and receive expert advice on emotional well-being and self-care.
Stephen Oh, MD, PhD
Associate Professor of Medicine
Co-Chief of the Division of Hematology
Washington University School of Medicine
Amy W. Zhou, MD
Associate Professor of Medicine
Division of Hematology
Washington University School of Medicine
Thank you to The Leukemia & Lymphoma Society, Imerman Angels, and the MPN Research Foundation for their partnerships. We are fortunate to work with such amazing partners that are here for you with information about clinical trials, resources, and support.
This program is more than just an information session—it's a vital resource for those affected by myeloproliferative neoplasms (MPNs). Hear from leading experts and patients, and uncover the latest advancements in treatments, including clinical trials and targeted therapies, to help you or your loved one navigate this journey with confidence and hope.
Thank you to GSK, Karyopharm, Novartis, and Sobi for their support of our patient education program! The Patient Story retains full editorial control over all content.